EVELYN LOPEZ-BRIGNONI: Open Payments
NPI 1306060256 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,939 in 59 payments from 12 companies in 2025. Trend: 2023 $1,916 · 2024 $2,067 · 2025 $1,939
Food & beverage: $1,939
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $1,118 |
| Supernus Pharmaceuticals, Inc. | 9 | $238 |
| Axsome Therapeutics, Inc. | 8 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| Janssen Pharmaceuticals, Inc | 4 | $83 |
| Almatica Pharma LLC | 4 | $78 |
| Neuronetics, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Corium, LLC | 1 | $21 |
Products named: VRAYLAR, Qelbree, Auvelity, CAPLYTA, INVEGA SUSTENNA, LOREEV XR, NEUROSTAR TMS THERAPY SYSTEM, HETLIOZ.
Industry payments across FL — which companies pay providers there.
